New England Journal of Medicine · 2010 · 176 citations · 21 references
MedicineGeneticsMolecular GeneticsBiochemical GeneticsBone MetabolismHuman GeneticsBone DevelopmentBone DisordersBone Metabolism GeneticsOsteogenesisOsteogenesis ImperfectaSkeletal DevelopmentBone Fragility DisordersOsteogenesis Imperfecta GeneticsRate LimitingRate-limiting Enzymes
Osteogenesis imperfecta is a heritable disorder that causes bone fragility. Mutations in type I collagen result in autosomal dominant osteogenesis imperfecta, whereas mutations in either of two components of the collagen prolyl 3-hydroxylation complex (cartilage-associated protein [CRTAP] and prolyl 3-hydroxylase 1 [P3H1]) cause autosomal recessive osteogenesis imperfecta with rhizomelia (shortening of proximal segments of upper and lower limbs) and delayed collagen folding. We identified two siblings who had recessive osteogenesis imperfecta without rhizomelia. They had a homozygous start-codon mutation in the peptidyl-prolyl isomerase B gene (PPIB), which results in a lack of cyclophilin B (CyPB), the third component of the complex. The proband's collagen had normal collagen folding and normal prolyl 3-hydroxylation, suggesting that CyPB is not the exclusive peptidyl-prolyl cis-trans isomerase that catalyzes the rate-limiting step in collagen folding, as is currently thought.
21
The Medical Journal of Australia · 1976 · 5.3K citations
Genetic heterogeneity in osteogenesis imperfecta.
David Sillence, A Senn, D. M. Danks · Journal of Medical Genetics · 1979 · 2.2K citations · Full text
Medicine, Genetics, Bone Metabolism +16
CRTAP Is Required for Prolyl 3- Hydroxylation and Mutations Cause Recessive Osteogenesis Imperfecta
Roy Morello, Terry Bertin, Yuqing Chen et al. · Cell · 2006 · 530 citations · Full text
Nelson's Textbook of Pediatrics 17th ed
Richard E. Behrman, et all · 2003 · 444 citations
Medicine, Child Health, Pediatrics +12